The Corporate Carrier Company
As one of the UK’s leading suppliers of printed carrier bags, The Corporate Carrier Company offers a wide range of promotional carrier bags, with the emphasis on providing superior customer service. We offer a wide range of printed carrier bags and promotional boxes or folders. Our high-quality products are manufactured in a choice of materials including printed paper bags, plastic/polythene, cotton and non-woven fabric – most of which are eco-friendly and biodegradable.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…
Company Details
Latest Content from PMHub
A Pharma Brand Manager’s Guide to Exhibiting
White Papers and Resources | March 5, 2026 | Apex Events and Exhibitions
Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what happens next? Exhibiting successfully involves...
Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care
Press Releases | March 2, 2026 | Medscape Education
The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...
Why stigma is a launch risk in rare disease – and what commercial leaders can do about it
White Papers and Resources | March 2, 2026 | Havas Life London
Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.
From ‘why’ to ‘how’: patient partnership across age groups in research and publications
White Papers and Resources | February 27, 2026 | Amiculum
By Sarah Mohamad
From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction
Press Releases | February 26, 2026 | Impetus Digital
Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...
Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden
Press Releases | February 25, 2026 | Medscape Education
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...
T40: when a number is not just a number
Press Releases | February 23, 2026 | Grace Communications
Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top 40 Creative Healthcare Agencies 2025.
Why patient engagement must come first in rare disease trials
White Papers and Resources | February 23, 2026 | Cuttsy + Cuttsy
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Press Releases | February 23, 2026 | Cuttsy + Cuttsy
Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...
#ShortenTheJourney
Press Releases | February 18, 2026 | Medscape Education
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...